 |
|
Thalidomide for the Treatment of Refractory Necrobiosis Lipoidica
Tarun Kukreja, MD;
Jeffrey Petersen, MD
Washington University, St Louis, Mo
Arch Dermatol. 2006;142:20-22.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
REPORT OF A CASE
A 51-year-old woman with a 2-year history of biopsy-proved necrobiosis lipoidica (NL) and a 10-year history of recurrent lower limb ulcerations was referred to the dermatology clinic because of a new ulceration on her right lower extremity. At her initial presentation, her physical examination was remarkable for 2 atrophic plaques with active disease and palpable reddish brown borders on her right lower extremity. The larger of the 2 plaques had a 3.0 x 2.0-cm ulceration. The left lower extremity had 3 atrophic plaques with similar palpable reddish brown borders (Figure 1). Although past ulcerations were related to trauma, the patient reported that the new ulcer had developed spontaneously and denied any history of diabetes. Multiple therapies, including intralesional and topical steroids, pentoxifylline, and compression, had been tried, with only partial healing of the ulceration. Her medical history was unremarkable, with no associated . . . [Full Text of this Article]
THERAPEUTIC CHALLENGE
SOLUTION
COMMENT
AUTHOR INFORMATION
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Treatment of Refractory Ulcerative Necrobiosis Lipoidica Diabeticorum With Infliximab: Report of a Case
Hu et al.
Arch Dermatol 2009;145:437-439.
ABSTRACT
| FULL TEXT
The Era of Cooperation
Heffernan
Arch Dermatol 2006;142:93-95.
FULL TEXT
|
